Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).
Kurisu K, Inada S, Maeda I, Nobata H, Ogawa A, Iwase S, Uchida M, Akechi T, Amano K, Nakajima N, Morita T, Sumitani M, Yoshiuchi K. Kurisu K, et al. Among authors: iwase s. Support Care Cancer. 2024 Feb 8;32(3):147. doi: 10.1007/s00520-024-08352-2. Support Care Cancer. 2024. PMID: 38326487 Free PMC article.
Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
Okuyama T, Yoshiuchi K, Ogawa A, Iwase S, Yokomichi N, Sakashita A, Tagami K, Uemura K, Nakahara R, Akechi T; Phase‐R Delirium Study Group. Okuyama T, et al. Among authors: iwase s. Oncologist. 2019 Jul;24(7):e574-e582. doi: 10.1634/theoncologist.2018-0242. Epub 2019 Jan 4. Oncologist. 2019. PMID: 30610009 Free PMC article.
Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings.
Maeda I, Ogawa A, Yoshiuchi K, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Sakashita A, Matsumoto Y, Uemura K, Nakahara R, Iwase S; Phase-R Delirium Study Group. Maeda I, et al. Among authors: iwase s. Gen Hosp Psychiatry. 2020 Nov-Dec;67:35-41. doi: 10.1016/j.genhosppsych.2020.09.001. Epub 2020 Sep 14. Gen Hosp Psychiatry. 2020. PMID: 32950826
Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational study.
Maeda I, Satomi E, Kiuchi D, Nishijima K, Matsuda Y, Tokoro A, Tagami K, Matsumoto Y, Naito A, Morita T, Iwase S; Phase-R N/V Study Group; Otani H, Odagiri T, Watanabe H, Mori M, Matsuda Y, Nagaoka H, Mayuzumi M, Kanai Y, Sakamoto N, Ariyoshi K. Maeda I, et al. Among authors: iwase s. Support Care Cancer. 2021 Oct;29(10):5831-5838. doi: 10.1007/s00520-021-06067-2. Epub 2021 Mar 20. Support Care Cancer. 2021. PMID: 33742244
A decision tree prediction model for a short-term outcome of delirium in patients with advanced cancer receiving pharmacological interventions: A secondary analysis of a multicenter and prospective observational study (Phase-R).
Kurisu K, Inada S, Maeda I, Ogawa A, Iwase S, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Nakahara R, Kaneishi K, Nakajima N, Sumitani M, Yoshiuchi K; Phase-R Delirium Study Group. Kurisu K, et al. Among authors: iwase s. Palliat Support Care. 2022 Apr;20(2):153-158. doi: 10.1017/S1478951521001565. Palliat Support Care. 2022. PMID: 35574912
485 results